Drug Profile
Etonogestrel/ethinylestradiol vaginal ring - Evestra
Alternative Names: EVE-112Latest Information Update: 27 Mar 2023
Price :
$50
*
At a glance
- Originator Evestra
- Developer Evestra; Gedeon Richter; Research Center Pharmaceutical Engineering
- Class Alkylated estrogenic steroids; Contraceptives; Hormonal contraceptives; Norpregnanes; Norpregnatrienes; Progesterone congeners
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Pregnancy
Most Recent Events
- 27 Mar 2023 Discontinued - Preclinical for Pregnancy (Prevention) in USA (Vaginal)
- 28 Oct 2019 No recent reports of development identified for preclinical development in Pregnancy(Prevention) in USA (Vaginal, Ring)
- 08 Dec 2018 Evestra completes a phase III trial in Pregnancy (Prevention) in Bulgaria and Poland (Vaginal) (EudraCT2016-002092-10)